Market

Bankers/Auditors/Registrars

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Natco Pharma Ltd.

GO
Market Cap. ( ₹ in Cr. ) 15787.64 P/BV 1.83 Book Value ( ₹ ) 482.93
52 Week High/Low ( ₹ ) 1059/727 FV/ML 2/1 P/E(X) 8.37
Book Closure 18/02/2026 EPS ( ₹ ) 105.26 Div Yield (%) 0.68
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]4411.603978.802696.901904.901690.30
Other Operating Revenues17.9020.0010.2039.90361.80
Total Operating Revenues4429.503998.802707.101944.802052.10
      
Other Income354.50128.10104.6099.00103.60
Total Revenue4784.004126.902811.702043.802155.70
      
EXPENSES     
Cost Of Materials Consumed536.20522.50475.30519.20372.90
Purchase Of Stock-In Trade166.10151.40175.7058.50186.60
Changes In Inventories Of FG,WIP And Stock-In Trade-12.5042.70-23.70-16.80-48.10
Employee Benefit Expenses594.50525.00486.70444.80414.90
Finance Costs23.9019.2014.5017.7013.30
Depreciation And Amortisation Expenses235.20186.80163.80142.60116.90
Other Expenses949.201005.80657.50675.60519.60
Total Expenses2492.602453.401949.801841.601576.10
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2291.401673.50861.90202.20579.60
      
Profit/Loss Before Tax2291.401673.50861.90202.20579.60
      
Tax Expenses-Continued Operations     
Current Tax437.60316.50162.7047.80147.80
Deferred Tax-29.60-31.30-16.10-15.60-10.60
Total Tax Expenses408.00285.20146.6032.20137.20
Profit/Loss After Tax And Before ExtraOrdinary Items1883.401388.30715.30170.00442.40
      
Profit/Loss From Continuing Operations1883.401388.30715.30170.00442.40
      
Profit/Loss For The Period1883.401388.30715.30170.00442.40
      
Minority Interest2.000.000.000.00-1.50
Consolidated Profit/Loss After MI And Associates1885.401388.30715.30170.00440.90
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)105.2677.3439.189.3224.20
Diluted EPS (Rs.)105.2677.3439.189.3224.16
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend107.50170.20100.4082.10113.80
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]4411.60
Other Operating Revenues17.90
Total Operating Revenues4429.50
Other Income354.50
Total Revenue4784.00
EXPENSES 
Cost Of Materials Consumed536.20
Purchase Of Stock-In Trade166.10
Changes In Inventories Of FG,WIP And Stock-In Trade-12.50
Employee Benefit Expenses594.50
Finance Costs23.90
Depreciation And Amortisation Expenses235.20
Other Expenses949.20
Total Expenses2492.60
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2291.40
Profit/Loss Before Tax2291.40
Tax Expenses-Continued Operations 
Current Tax437.60
Deferred Tax-29.60
Total Tax Expenses408.00
Profit/Loss After Tax And Before ExtraOrdinary Items1883.40
Profit/Loss From Continuing Operations1883.40
Profit/Loss For The Period1883.40
Minority Interest2.00
Consolidated Profit/Loss After MI And Associates1885.40
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)105.26
Diluted EPS (Rs.)105.26
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend107.50
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.